Nov 29, 2022 / 04:20PM GMT
Umer Raffat - Evercore ISI Institutional Equities, Research Division - Senior MD & Senior Analyst of Equity Research
Excellent. Thank you, guys. Thanks for joining us. Pleasure to have Amgen management join us. But before we start, I always love turning it over to Arvind, who I feel like framed it so well. So Arvind, over to you.
Arvind Sood - Amgen Inc. - VP of IR
Umer, thanks so much for inviting us to your conference. And I was just talking to Dave earlier that there's great news that you're planning on having this conference in Miami this year or next year.
Umer Raffat - Evercore ISI Institutional Equities, Research Division - Senior MD & Senior Analyst of Equity Research
That's right.
Arvind Sood - Amgen Inc. - VP of IR
Let me just kind of tee up some of the kind of the broader picture or some of the key topics. I am obviously delighted that we have David Reese, our kind of research and development with us. And with all of what we have going on with the pipeline
Amgen Inc at Evercore ISI HealthCONx Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot